SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914208-15-000273
Filing Date
2015-02-11
Accepted
2015-02-11 16:45:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 REPLIGEN CORPORATION 12312014 repligencorporation12312014.htm SC 13G 35947
2 JOINT FILING AGREEMENT 12312014 jfa12312014.htm EX-99 21461
  Complete submission text file 0000914208-15-000273.txt   59268
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-38071 | Film No.: 15600149
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309
Business Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

IRS No.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice